OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
SBUX Starbucks Corp
MRDY Mobile Ready Entertainment Corp
MANT ManTech International Corp
LXFR Luxfer Holdings PLC
SYZLF Sylogist Ltd
BSX Boston Scientific Corp
PNGAY Ping An Insurance Group Co of China Ltd
GLOP GasLog Partners LP
AGNC Agnc Investment Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Price
Delayed
$10.99
Day's Change
0.43 (4.07%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.06
Day's Low
10.60
Volume
(Light)

Today's volume of 84,409 shares is on pace to be much lighter than OSUR's 10-day average volume of 1,337,196 shares.

84,409

OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications

7:00 am ET May 17, 2021 (Globe Newswire) Print

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Scott Gleason has been appointed Senior Vice President Investor Relations and Corporate Communications effective today.

Prior to joining OraSure, Mr. Gleason served as the Senior Vice President of Investor Relations and Corporate Strategy for Myriad Genetics, Inc., a leading specialty diagnostic laboratory in the United States focused on genetic testing and precision medicine. At Myriad, he managed the investor relations and corporate communications functions, led the annual strategic planning process, and was a member of the Company's strategic committee. Prior to his tenure with Myriad Genetics, Mr. Gleason was a senior publishing analyst at Stephens, Inc. from 2005 to 2013 covering the life science tools and diagnostics industry. Before joining Stephens, Inc. Mr. Gleason was a United States Air Force aircraft maintenance officer and participated in two wartime deployments. Mr. Gleason received a Bachelor of Science degree from the U.S. Air Force Academy in Colorado Springs, CO.

"We are delighted to welcome Scott as the Company's new Senior Vice President Investor Relations and Corporate Communications. Scott comes to OraSure with over 20 years of executive leadership experience focused in investment banking, investor relations, corporate communications, and corporate strategy and business development. His extensive experience gives him a unique insight that will make him a strong addition to OraSure's executive team as the Company advances its work to help solve the world's greatest health challenges," said Stephen S. Tang, Ph.D., President and CEO of OraSure Technologies.

About OraSure Technologies

OraSure Technologies, Inc. (NASDAQ: OSUR) empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly owned subsidiaries, DNA Genotek, Diversigen and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. For more information on OraSure Technologies, please visit www.orasure.com.

Investor Contact:         Media Contact:
Sam Martin                Jeanne Mell
Argot Partners            VP Corporate Communications
212-600-1902              484-353-1575
orasure@argotpartners.com media@orasure.com

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

comtex tracking

COMTEX_386745219/2010/2021-05-17T07:00:01

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.